Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study. (December 2020)
- Record Type:
- Journal Article
- Title:
- Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study. (December 2020)
- Main Title:
- Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas
- Authors:
- Tatekawa, Hiroyuki
Yao, Jingwen
Oughourlian, Talia C.
Hagiwara, Akifumi
Wang, Chencai
Raymond, Catalina
Lai, Albert
Cloughesy, Timothy F.
Nghiemphu, Phioanh L.
Liau, Linda M.
Salamon, Noriko
Ellingson, Benjamin M. - Abstract:
- Abstract : Purpose: We evaluated 18 F-FDOPA PET and MRI characteristics in association with the molecular status and overall survival (OS) in a large number of low-grade gliomas (LGGs). Methods: Eighty-six patients who underwent 18 F-FDOPA PET and MRI and were diagnosed with new or recurrent LGGs were retrospectively evaluated with respect to their isocitrate dehydrogenase (IDH) and 1p19q status (10 IDH wild type, 57 mutant, 19 unknown; 1p19q status in IDH mutant: 20 noncodeleted, 37 codeleted). After segmentation of the hyperintense area on fluid-attenuated inversion recovery image (FLAIRROI ), the following were calculated: normalized SUVmax (nSUVmax) of 18 F-FDOPA relative to the striatum, 18 F-FDOPA hypermetabolic volume (tumor-to-striatum ratios >1), FLAIRROI volume, relative cerebral blood volume, and apparent diffusion coefficient within FLAIRROI . Receiver operating characteristic curve and Cox regression analyses were performed. Results: PET and MRI metrics combined with age predicted the IDH mutation and 1p19q codeletion statuses with sensitivities of 73% and 76% and specificities of 100% and 94%, respectively. Significant correlations were found between OS and the IDH mutation status (hazard ratio [HR] = 4.939), nSUVmax (HR = 2.827), 18 F-FDOPA hypermetabolic volume (HR = 1.048), and FLAIRROI volume (HR = 1.006). The nSUVmax (HR = 151.6) for newly diagnosed LGGs and the 18 F-FDOPA hypermetabolic volume (HR = 1.038) for recurrent LGGs demonstrated significantAbstract : Purpose: We evaluated 18 F-FDOPA PET and MRI characteristics in association with the molecular status and overall survival (OS) in a large number of low-grade gliomas (LGGs). Methods: Eighty-six patients who underwent 18 F-FDOPA PET and MRI and were diagnosed with new or recurrent LGGs were retrospectively evaluated with respect to their isocitrate dehydrogenase (IDH) and 1p19q status (10 IDH wild type, 57 mutant, 19 unknown; 1p19q status in IDH mutant: 20 noncodeleted, 37 codeleted). After segmentation of the hyperintense area on fluid-attenuated inversion recovery image (FLAIRROI ), the following were calculated: normalized SUVmax (nSUVmax) of 18 F-FDOPA relative to the striatum, 18 F-FDOPA hypermetabolic volume (tumor-to-striatum ratios >1), FLAIRROI volume, relative cerebral blood volume, and apparent diffusion coefficient within FLAIRROI . Receiver operating characteristic curve and Cox regression analyses were performed. Results: PET and MRI metrics combined with age predicted the IDH mutation and 1p19q codeletion statuses with sensitivities of 73% and 76% and specificities of 100% and 94%, respectively. Significant correlations were found between OS and the IDH mutation status (hazard ratio [HR] = 4.939), nSUVmax (HR = 2.827), 18 F-FDOPA hypermetabolic volume (HR = 1.048), and FLAIRROI volume (HR = 1.006). The nSUVmax (HR = 151.6) for newly diagnosed LGGs and the 18 F-FDOPA hypermetabolic volume (HR = 1.038) for recurrent LGGs demonstrated significant association with OS. Conclusions: Combining 18 F-FDOPA PET and MRI with age proved useful for predicting the molecular status in patients with LGGs, whereas the nSUVmax and 18 F-FDOPA hypermetabolic volume may be useful for prognostication. Abstract : Supplemental digital content is available in the text. … (more)
- Is Part Of:
- Clinical nuclear medicine. Volume 45:Number 12(2020)
- Journal:
- Clinical nuclear medicine
- Issue:
- Volume 45:Number 12(2020)
- Issue Display:
- Volume 45, Issue 12 (2020)
- Year:
- 2020
- Volume:
- 45
- Issue:
- 12
- Issue Sort Value:
- 2020-0045-0012-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-12
- Subjects:
- 18F-FDOPA PET -- low-grade glioma -- molecular biomarker -- overall survival
Nuclear medicine -- Periodicals
Radioisotope scanning -- Periodicals
Nuclear Medicine -- Periodicals
616.07575 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00003072-000000000-00000 ↗
http://journals.lww.com/nuclearmed/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/RLU.0000000000003318 ↗
- Languages:
- English
- ISSNs:
- 0363-9762
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.314000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21508.xml